EANS-Adhoc LifeWatch AG: Kenneth Melani designated as new Chairman. Yacov Geva will continue to act as the Corporate CEO. (with document)

    Nachrichtenagentur: news aktuell
     |  25.03.2013, 16:02  |  369 Aufrufe  |   | 
    --------------------------------------------------------------------------------
    ad-hoc disclosure transmitted by euro adhoc with the aim of a Europe-wide
    distribution. The issuer is solely responsible for the content of this
    announcement.

    --------------------------------------------------------------------------------

    Board of Directors (Appointments and Changes)/Company
    Information/LifeWatch AG 25.03.2013

    Neuhausen am Rheinfall/Switzerland - LifeWatch AG (SIX Swiss
    Exchange: LIFE), the leading provider of wireless telemedicine, today
    announces a change for the Chair of its Board of Directors. Subject
    to his re-election at the upcoming ordinary shareholder meeting on
    May 29, 2013, the current Board member Kenneth Melani will then take
    the Chair of the Board of Directors. The present Chairman and CEO Dr.
    Yacov Geva will continue to act as the Corporate CEO of LifeWatch AG.

    You will find a PDF-version of this press release at the end of this
    message.

    LifeWatch AG announces today that its Board member Kenneth Melani
    will take the Chair of the Board of Directors from Dr. Yacov Geva
    subject to his re-election at the upcoming ordinary shareholder
    meeting on May 29, 2013. On the occasion of the extraordinary
    shareholder meeting on January 23, 2013, Kenneth Melani was elected a
    member of the Board based on his longstanding experience and intimate
    knowledge of the U.S. healthcare system. Currently, the Company is
    creating about 99% of its revenues in the United States.

    The long-time Chairman and Chief Executive Officer of LifeWatch AG,
    Dr. Yacov Geva, will continue to act as the Corporate CEO in order to
    grow the existing and future business of the Company together with
    the new Chairman Kenneth Melani.

    Kenneth R. Melani (born 1954, citizen of the U.S.) is the former
    president and chief executive officer of Highmark, a health insurance
    company based in Pittsburgh and the largest health insurer in
    Pennsylvania. He graduated in 1975 with a chemistry degree and
    enrolled later in the Bowman Gray School of Medicine in North
    Carolina before specializing in adult internal medicine. In 1982, he
    started his own practice in Pennsylvania. Later he began to take on
    work for West Penn Cares, a company of West Penn-affiliated
    physicians, developing business opportunities with a commercial blood
    laboratory and in- home intravenous therapy devices. In 1989, he was
    appointed chief medical officer for Blue Cross of Western
    Pennsylvania. During this time, Blue Cross of Western Pennsylvania
    merged with Harrisburg's Pennsylvania Blue Shield and the company was
    re-christened Highmark. Kenneth Melani was awarded W&J College's
    "Entrepreneur of the Year Award" in 2009.

    About LifeWatch AG:

    LifeWatch AG, headquartered in Neuhausen am Rheinfall and listed on
    SIX Swiss Exchange (LIFE), Switzerland, is the leading healthcare
    technology and solution company, specializing in advanced telehealth
    systems and wireless remote patient monitoring services. LifeWatch
    services cater to individuals, ranging from high-risk and chronically
    ill patients, to consumers of health and wellness products. LifeWatch
    AG has operative subsidiaries in the United States, in Switzerland
    and in Israel and is the parent company of LifeWatch Services Inc.,
    and LifeWatch Technologies, Ltd. LifeWatch Services, Inc. is a
    leading US-based provider of cardiac monitoring services and home
    sleep testing of Obstructive Sleep Apnea (OSA). LifeWatch
    Technologies Ltd., based in Israel, is a leading developer and
    manufacturer of telemedicine products. The Company is planning to
    introduce the LifeWatch V, an Android-based smartphone with medical
    sensors and apps that uses a cloud-based service platform. For
    additional information, please visit www.lifewatch.com.

    Sign-up for customized E-mail alerts and documentation requests is
    available at http://production.investis.com/lifewatch/alert-service/

    This press release includes forward-looking statements. All
    statements other than statements of historical facts contained in
    this press release, including statements regarding future results of
    operations and financial position, business strategy and plans and
    objectives for future operations, are forward- looking statements.
    The words "believe," "may," "will," "estimate," "continue,"
    "anticipate," "intend,""expect" and similar expressions are intended
    to identify forward-looking statements. LifeWatch AG has based these
    forward-looking statements largely on current expectations and
    projections about future events and financial trends that it believes
    may affect the financial condition, results of operations, business
    strategy, short term and long term business operations and
    objectives, and financial needs. These forward-looking statements are
    subject to a number of risks, uncertainties and assumptions. In light
    of these risks, uncertainties and assumptions, the forward-looking
    events and circumstances described may not occur and actual results
    could differ materially and adversely from those anticipated or
    implied in the forward- looking statements. All forward-looking
    statements are based only on data available to LifeWatch AG at the
    time of the issue of this press release. LifeWatch AG does not
    undertake any obligation to update any forward-looking statements
    contained in this press release as a result of new information,
    future events or otherwise.

    THIS PRESS RELEASE IS NOT BEING ISSUED IN THE UNITED STATES OF
    AMERICA AND SHOULD NOT BE DISTRIBUTED TO UNITED STATES PERSONS OR
    PUBLICATIONS WITH A GENERAL CIRCULATION IN THE UNITED STATES. THIS
    PRESS RELEASE DOES NOT CONSTITUTE AN OFFER OF SECURITIES OF LIFEWATCH
    AG OR ANY OF ITS SUBSIDIARIES FOR SALE IN THE UNITED STATES OR AN
    INVITATION TO SUBSCRIBE FOR OR PURCHASE ANY SECURITIES OF LIFEWATCH
    AG OR ITS SUBSIDIARIES IN THE UNITED STATES. IN ADDITION, THE
    SECURITIES OF LIFEWATCH AG AND ITS SUBSIDIARIES HAVE NOT BEEN
    REGISTERED UNDER THE UNITED STATES SECURITIES LAWS AND MAY NOT BE
    OFFERED, SOLD OR DELIVERED WITHIN THE UNITED STATES OR TO U.S.
    PERSONS ABSENT REGISTRATION UNDER OR AN APPLICABLE EXEMPTION FROM THE
    REGISTRATION REQUIREMENTS OF THE UNITED STATES SECURITIES LAWS. ANY
    PUBLIC OFFERING OF SECURITIES TO BE MADE IN THE UNITED STATES WILL BE
    MADE BY MEANS OF A PROSPECTUS THAT MAY BE OBTAINED FROM LIFEWATCH AG
    OR ITS SUBSIDIARIES, AS APPLICABLE, AND WILL CONTAIN DETAILED
    INFORMATION ABOUT THE ISSUER AND ITS MANAGEMENT AS WELL AS FINANCIAL
    STATEMENTS OF THE ISSUER.

    Attachments with Announcement:
    ----------------------------------------------
    http://resources.euroadhoc.com/us/jG8iMykS

    Further inquiry note:
    Sensus Communication Consultants, Zürich:

    Tel +41 43 366 55 11 | Fax +41 43 366 55 12 | Email lifewatch@sensus.ch

    end of announcement euro adhoc
    --------------------------------------------------------------------------------

    Attachments with Announcement:

    ----------------------------------------------

    http://resources.euroadhoc.com/us/jG8iMykS



    issuer: LifeWatch AG
    Rundbuckstrasse 6
    CH-8212 Neuhausen am Rheinfall
    phone: +41 52 632 00 50
    FAX: +41 52 632 00 51
    mail: users@lifewatch.com
    WWW: www.lifewatch.com
    sector: Healthcare Providers
    ISIN: CH0012815459
    indexes: SPI, SPIEX
    stockmarkets: free trade: Berlin, Open Market / XETRA: Frankfurt, Main Standard:
    SIX Swiss Exchange
    language: English


    Wertpapier: LifeWatch N

    Themen: UBSSECIFE


    Schreibe Deinen Kommentar

     

    Disclaimer

    Enthaltene Werte

    WertpapierKursZeitPerf. %
    9,199
    19.12.
    +2,23

    Nachrichtenagentur

    Weitere Nachrichten des Autors

    TitelLeser
    148
    127
    118
    117
    115
    TitelLeser
    430
    208
    191
    181
    179
    TitelLeser
    1018
    920
    870
    860
    849
    TitelLeser
    7602
    5097
    4102
    4091
    3929

    Top Nachrichten aus der Rubrik